Baker Brothers Life Sciences Capital, L.P. - Net Worth and Insider Trading

Baker Brothers Life Sciences Capital, L.P. Net Worth

The estimated net worth of Baker Brothers Life Sciences Capital, L.P. is at least $11.6 Billion dollars as of 2024-06-23. Baker Brothers Life Sciences Capital, L.P. is the 2201 Interest of corporation controlled by you of BeiGene Ltd and owns about 126,893,311 shares of BeiGene Ltd (HKSE:06160) stock worth over $11.6 Billion. Details can be seen in Baker Brothers Life Sciences Capital, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Baker Brothers Life Sciences Capital, L.P. has not made any transactions after 2023-11-14 and currently still holds the listed stock(s).

Transaction Summary of Baker Brothers Life Sciences Capital, L.P.

To

Baker Brothers Life Sciences Capital, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Baker Brothers Life Sciences Capital, L.P. owns 1 companies in total, including BeiGene Ltd (HKSE:06160) .

Click here to see the complete history of Baker Brothers Life Sciences Capital, L.P.’s form 4 insider trades.

Insider Ownership Summary of Baker Brothers Life Sciences Capital, L.P.

Ticker Comapny Transaction Date Type of Owner
HKSE:06160 BeiGene Ltd 2023-11-14 2201 Interest of corporation controlled by you

Baker Brothers Life Sciences Capital, L.P. Latest Holdings Summary

Baker Brothers Life Sciences Capital, L.P. currently owns a total of 1 stock. Baker Brothers Life Sciences Capital, L.P. owns 126,893,311 shares of BeiGene Ltd (HKSE:06160) as of November 14, 2023, with a value of $11.6 Billion.

Latest Holdings of Baker Brothers Life Sciences Capital, L.P.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06160 BeiGene Ltd 2023-11-14 126,893,311 91.50 11,610,737,957

Holding Weightings of Baker Brothers Life Sciences Capital, L.P.


Baker Brothers Life Sciences Capital, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, Baker Brothers Life Sciences Capital, L.P. has made a total of 2 transactions in BeiGene Ltd (HKSE:06160) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in BeiGene Ltd is the sale of 13,112,580 shares on November 14, 2023, which brought Baker Brothers Life Sciences Capital, L.P. around $0.

Insider Trading History of Baker Brothers Life Sciences Capital, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Baker Brothers Life Sciences Capital, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Baker Brothers Life Sciences Capital, L.P. Ownership Network

Ownership Network List of Baker Brothers Life Sciences Capital, L.P.

No Data

Ownership Network Relation of Baker Brothers Life Sciences Capital, L.P.

Insider Network Chart

Baker Brothers Life Sciences Capital, L.P. Owned Company Details

What does BeiGene Ltd do?

Who are the key executives at BeiGene Ltd?

Baker Brothers Life Sciences Capital, L.P. is the 2201 Interest of corporation controlled by you of BeiGene Ltd. Other key executives at BeiGene Ltd include 2101 Beneficial owner Oyler John Victor , 2502 Approved lending agent JPMorgan Chase & Co. , and 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. .

BeiGene Ltd (HKSE:06160) Insider Trades Summary

Over the past 18 months, Baker Brothers Life Sciences Capital, L.P. made 1 insider transaction in BeiGene Ltd (HKSE:06160) with a net sale of 13,112,580. Other recent insider transactions involving BeiGene Ltd (HKSE:06160) include a net purchase of 14,449,821 shares made by JPMorgan Chase & Co. , a net sale of 559,949 shares made by Oyler John Victor , and a net purchase of 2,302,280 shares made by The Capital Group Companies, Inc. .

In summary, during the past 3 months, insiders sold 220,701 shares of BeiGene Ltd (HKSE:06160) in total and bought 0 shares, with a net sale of 220,701 shares. During the past 18 months, 59,036,556 shares of BeiGene Ltd (HKSE:06160) were sold and 19,216,128 shares were bought by its insiders, resulting in a net sale of 39,820,428 shares.

BeiGene Ltd (HKSE:06160)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BeiGene Ltd Insider Transactions

No Available Data

Baker Brothers Life Sciences Capital, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for Baker Brothers Life Sciences Capital, L.P.. Currently GuruFocus does not have mailing address information for Baker Brothers Life Sciences Capital, L.P..

Discussions on Baker Brothers Life Sciences Capital, L.P.

No discussions yet.